StayAlert Search Results
Search results for: "fda"
323 results (showing 1 through 25)
... are encouraged to report any adverse events to FDA's MedWatch Adverse Event Reporting Program. Resources: * External Links * FDA 2017 Medical Product ...
... .accessdata.fda.gov/scripts/cdrh/cfdocs/cfRES/res.cfm?id=154969&source= govdelivery&utm_medium=email&utm_source=govdelivery) (grafts with a proximal ...
See the press release (http://links.govdelivery.com/track?type=click&enid== &&&100&&&https://www.fda.gov/Safety/Recalls/ucm571787.htm?source= ...
Through recent communication with FDA, the distribution firm Rugby Laboratories learned of a potential issue with a product manufactured by PharmaTech LLC.
The US Food and Drug Administration (FDA) is issuing an update to alert health care providers of five reports of unanticipated deaths that occurred from 2016 to ...
The US Food and Drug Administration (FDA) is alerting health care professionals and patients not to use drug products intended to be sterile that are produced ...
Rugby® Laboratories learned of the potential issue through recent communication with the FDA. FDA has informed Rugby that it received several adverse event ...
The Centers for Disease Control and Prevention (CDC), State and Local Health Departments, and the Food and Drug Administration (FDA) are investigating an ...
The US Food and Drug Administration (FDA) has classified this recall as Class I, the most serious type of recall, as use of these devices may cause serious ...
BACKGROUND: On March 10, 2017, the FDA received an adverse event report concerning a 30-year-old female patient who experienced cardiac arrest after IV ...
... to the FDA's MedWatch Safety Information and Adverse Event Reporting Program. Resources: * External Links * FDA 2017 FDA Medical Product Safety Alert.
The US Food and Drug Administration (FDA) received adverse event reports on April 5 and June 1, 2017, and conducted follow-up, concerning at least 43 ...
... of these products to the FDA's MedWatch Safety Information and Adverse Event Reporting Program. Resources: * External Links * FDA 2017 Medical Product ...
... of this product may be reported to the FDA's MedWatch Adverse Event Reporting program. Resources: * External Links * FDA 2017 Medical Product Safety Alert.
The US Food and Drug Administration (FDA) is announcing the Class I Recall for the Oscor ATAR Reusable Extension Cable and the Oscor ATAR Disposable ...
The FDA cleared the updated design and labeling for the ED-530XT on July 21, 2017 As noted in the FDA's February 2015 Safety Communication, the complex ...
Penumbra Inc. is recalling the Penumbra 3D Revascularization device because there is a risk of the delivery wire breaking or separating during use. Fractured ...
The Food and Drug Administration (FDA)-approved prescribing information for eculizumab includes a black box warning for increased risk of meningococcal ...
... of these products to the FDA's MedWatch Safety Information and Adverse Event Reporting Program. Resources: * External Links * FDA 2017 Medical Product ...
See the press release (http://links.govdelivery.com/track?type=click&enid== &&&100&&&https://www.fda.gov/Safety/Recalls/ucm565936.htm?source= ...
There have many multiple reports of the Petya ransomware attacks throughout the world since Tuesday June 27, 2017. According to NPR ...
This is a secondary recall based on a Hospira's recent recall (https://www.fda.gov /Safety/Recalls/ucm563383.htm). These products were not distributed directly ...
... related to the use of these products to the FDA's MedWatch Safety Information and Adverse Event Reporting Program (http://www.fda.gov/MedWatch/report).
See the Recall Notice (https://www.fda.gov/MedicalDevices/Safety/ListofRecalls/ ucm564092.htm) for a list of affected lot numbers. Distribution Dates: May 7, ...
s June 15, 2017 recall announcement (http://links.govdelivery.com/track?type= click&enid==&&&100&&&https://www.fda.gov/Safety/MedWatch/SafetyInformation ...
Previous Page Next Page